Colorectal cancer is the third most common diagnosed cancer in the United States,
accounting for approximately 10% of cancer deaths overall. Reductions in mortality can be …

Colorectal cancer (CRC) is the third most common cancer diagnosed and the third most
common cause of cancer deaths among men in the United States. Although CRC screening …

La realización de tests de sangre oculta en heces (TSOH) para la detección precoz del
cáncer de colon necesita ser potenciada entre la población. El objetivo del presente estudio …

In our recent study (Marlow et al, 2021), we tested the impact of potential candidate
messages on intention to attend screening for inclusion in an age-targeted infographic. We …

Colorectal Cancer (CRC) screening is offered in the UK to individuals aged 60-75 years
through the faecal occult blood test (FOBt). Uptake of CRC screening is variable but …

Steady increases in breast cancer burden have recently been observed in Ghana. Despite
the low incidence of the disease compared with other African countries, breast cancer …

The purpose of this naturalistic inquiry was to understand factors that influence patients'
commitment to colorectal cancer screening, specifically colonoscopy. Fifteen personcentred …

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and second
in females; throughout the world over 1.2 million new CRC cases and 608, 7000 deaths are …

Many developed countries have begun to focus on the need to prevent mortality from non-
communicable diseases such as cancer. One of the cornerstones of this effort has been the …

Colorectal cancer (CRC) is the second most common cause of cancer death in the UK.
Since the introduction of the NHS Bowel Cancer Screening Programme CRC incidence and …